Apr 11,2018

Livongo gets $105 million funding in Series E

Digital chronic disease management company Livongo has raised $105 million in new Series E funding, mostly from existing investors. General Catalyst and Swedish investment company Kinnevik led the round, with additional participation from existing investors DFJ, Kleiner Perkins Caufield & Byers , Merck Global Health Innovation Fund, Microsoft Ventures, Sapphire Ventures, Zaffre Investments, and 7wire Ventures. The company also announced a partnership with nonprofit health insurance company Cambia Health Solutions.

FUNDING SERIES E
View Analyst & Ambassador Comments
Go to original news
Apr 04,2018

Virta Health Raises $45 Million to Expand Treatment for Type 2 Diabetes Reversal

Virta Health, the first company with a clinically-proven treatment to safely and sustainably reverse type 2 diabetes (T2D) and other chronic metabolic diseases without the use of medications or surgery, announced it has raised a $45 million Series B funding round, bringing the total equity funding to $75 million to date. Key existing investors including Venrock, Obvious Ventures, Creandum, Caffeinated Capital, and Max Levchin’s SciFi VC participated in the round, along with new investors including Founders Fund and Playground Global.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
Aug 06,2018

Evidation Health Announces $30 Million in New Funding

Evidation Health, a health and measurement company that helps life sciences and health care companies understand how everyday behaviors and health interact, announced today that it has raised $30 million in Series C funding. Already, the platform is being used to invent new ways to measure health across diabetes and cognitive decline. This complements the work that the company is performing with partners across multiple therapeutic areas ranging from cardiovascular disease to chronic pain, rheumatoid arthritis, migraine, depression and anxiety, fatigue, heart failure, and asthma — to name a few.

FUNDING SERIES C
View Analyst & Ambassador Comments
Go to original news
Sep 04,2018

DIAMONTECH COLLECTS 5 MILLION EUROS

DiaMonTech GmbH, a technology company specializing in methods for non-invasive blood glucose measurement, has successfully completed its second round of financing. The company received a total of around 5 million euros from old and new investors. The IBB Beteiligungsgesellschaft from Berlin, the Japanese electronics group Macnica and the Chinese venture capitalist Jindong Capital are the largest investors. DiaMonTech intends to use the money to advance the development of non-invasive blood sugar measurement with its patented, optical process.

FUNDING SEED ROUND
View Analyst & Ambassador Comments
Go to original news
Sep 05,2018

Fit4D (now named Cecelia Health) Raises Additional $4 Million To Fuel Growth and Product Innovation

Fit4D (now named Cecelia Health), a leading diabetes management technology services company based in New York City, announced an expansion financing led by existing investor SJF Ventures with new investors C&B Capital, Esther Dyson and North Haven Capital. Existing investors Blue Cross and Blue Shield of Nebraska and StartUp Health also participated in the round.

FUNDING VENTURE ROUND
View Analyst & Ambassador Comments
Go to original news
Sep 14,2018

DarioHealth Closes on $10,345,000 Through Private Placement Offering

DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with mobile health and big data solutions, announced today that it has closed on a private placement offering with institutional and private investors for the sale of shares of the Company's common stock and shares of the Company's newly designated Series D convertible preferred stock. As a part of this private placement, which raised $10,345,000 in the aggregate before expenses and placement agent fees, the Company issued 4,266,800 shares of common stock at a price per share of $0.90.

FUNDING SERIES D
View Analyst & Ambassador Comments
Go to original news
Nov 07,2018

Brighter receives SEK 0.8 M through exercise of warrants.

The exercise period for Brighter’s warrants of series TO3 is now completed. The company thereby strengthens its financing with SEK 837 628, representing 209 407 new shares and votes.

FUNDING VENTURE ROUND
View Analyst & Ambassador Comments
Go to original news
Dec 13,2018

Tidepool lands $6M grant to develop hybrid closed-loop automated insulin delivery app

Diabetes management startup Tidepool has just locked in a $6 million grant from the Leona M. and Harry B. Helmsley Charitable Trust and JDRF in order to kick off develop an app for hybrid closed-loop automated insulin delivery.

FUNDING GRANT
View Analyst & Ambassador Comments
Go to original news
Jan 05,2017

Intuity Medical gets another $15M to commercialize blood glucose monitoring system

Diabetes management device maker Intuity Medical has raised another $15 million in Series C funding in a round led by PTV Healthcare Capital, new investors KCK Group, and affiliates of Luther King Capital Management. Existing investors Accuitive Medical Ventures, Investor Growth Capital, US Venture Partners, Venrock and Versant Ventures also contributed to the round. The company, which makes an automatic blood glucose monitoring system called Pogo, raised $40 million just two months ago, bringing the Series total to $55 million. Pogo received FDA clearance in April 2016, and consists of a...

FUNDING SERIES C
View Analyst & Ambassador Comments
Go to original news
Jan 18,2017

Pops! Diabetes Care raises $1.2M for smartphone-connected glucometer

Minnesota-based Pops! Diabetes Care , which is working on a digital device and diabetes management platform, has raised a little over $1.2 million to bring its product to market. MedCity News confirmed the funding with Pops! CEO and cofounder Lonny Stormo, who previously served in executive roles at Medtronic. The Pops! system consists of an integrated blood glucose meter affixed to the back of a user’s smartphone and a Bluetooth-connected companion app.

FUNDING SEED ROUND

#bgm

#mobile app

View Analyst & Ambassador Comments
Go to original news
Subscribe to FUNDING